ijms-logo

Journal Browser

Journal Browser

Liver Tissue Damage and Repair

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Pathology, Diagnostics, and Therapeutics".

Deadline for manuscript submissions: closed (29 November 2023) | Viewed by 1320

Special Issue Editor

Special Issue Information

Dear Colleauges,

The liver is a “frontier” organ located between two different “worlds”. The first world is the “external world”, which comprises all the nutrients necessary for normal growth and functioning of the body, on the other hand, potentially dangerous components, such as excess of calorie intake, alcoholic beverages, bacteria, bacterial components, viruses, xenobiotics, etc., introduced daily into the body via food through the alimentary tract. The second world is the “internal world” which depends on the delivery of energy sources, hormones and minerals to keep the body functioning under normal and under “emergency” conditions. Under normal conditions, the liver(hepatocyte) takes up the elements from the nutrients absorbed through the small intestine and the waste (Kupffer cells) from the large intestine, both reaching the liver through the portal blood. From the arterial blood of the systemic circulation, the liver takes up xenobiotics (hepatocytes) and “waste” material such as aged erythrocytes, corpuscolate matters and microorganisms reaching systemic circulation trough the blood (Kupffer cells) and hormones from the adrenal glands, thyroid and from the hypophysis (hepatocyte). The most important cells physiologically involved in liver function are the hepatocyte and the liver macrophage, the Kupffer cell. Although the functional “plasticity” of the liver is such that it can clear large amounts of noxious material, when the quality or quantity of the “waste” overcomes the intracellular defense mechanisms it can lead to recruitment of inflammatory cells and to hepatocellular damage.

The damaged cells are then cleared by the mononuclear phagocytes and restitutio ad integrum takes place. In cases of continuous exposure of the liver to the noxious agents and to the inflammatory cells replacement of the damaged cells with healthy ones is no more possible and structural tissue changes become necessary. Liver fibrosis progresses to cirrhosis. As a consequence, hepatic blood supply switches from the mainly portal blood to arterial blood from the hepatic artery. This leads to the so called capillarisation of the sinusoids in the “restructured” remaining liver tissue. Portal blood then reaches the vena cava through collateral vessels of the portal vein, which develop into true varices in the lower esophagus and stomach.

If the noxious agent(s) is eliminated however, a reversible stage can follow. If not, cirrhosis can further progress to an irreversible shrinkage of the organ. Functional activity is then strongly reduced to a minimum(rest) which is provided by the maximally engaged remaining parenchymal and non-parenchymal cells. This functional capacity can be further reduced by the persistence of inflammatory infiltrate and ongoing cellular damage. Under this condition the risk of cancer development reaches 5-8%/year and decompensation symptoms become apparent.

Suggested Topics:

  1. Cellular pathology in acute and chronic liver damage of different origin in human liver
  2. Nutrition and the liver: how can we decide alcoholic, non-alcoholic?
  3. Iron, copper and the liver
  4. The liver and the endocrine system in health and disease
  5. Hepatotropic viruses and liver diseases: Clinics and liver pathology
  6. Liver and radiobiology: just another damaging agent?
  7. Intracellular defense mechanisms in liver cells (hepatocyte, Kupffer cell)
  8. Mechanisms of inflammation in acute and in “chronic” liver damage
  9. Mechanisms of damage and repair: Ischemia-ripe fusion injury
  10. Fibrosis, cirrhosis: mechanisms of development and clinical consequences
  11. How can we stop fibrosis development and when does it make sense?
  12. Tumor development: What is special in the liver?

Prof. Dr. Giuliano Ramadori
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

22 pages, 4959 KiB  
Article
Human Amniotic MSC Response in LPS-Stimulated Ascites from Patients with Cirrhosis: FOXO1 Gene and Th17 Activation in Enhanced Antibacterial Activation
by Mariangela Pampalone, Nicola Cuscino, Gioacchin Iannolo, Giandomenico Amico, Camillo Ricordi, Giampiero Vitale, Claudia Carcione, Salvatore Castelbuono, Simone Dario Scilabra, Claudia Coronnello, Salvatore Gruttadauria and Giada Pietrosi
Int. J. Mol. Sci. 2024, 25(5), 2801; https://doi.org/10.3390/ijms25052801 - 28 Feb 2024
Viewed by 773
Abstract
Spontaneous bacterial peritonitis (SBP) is a severe complication in patients with decompensated liver cirrhosis and is commonly treated with broad spectrum antibiotics. However, the rise of antibiotic resistance requires alternative therapeutic strategies. As recently shown, human amnion-derived mesenchymal stem cells (hA-MSCs) are able, [...] Read more.
Spontaneous bacterial peritonitis (SBP) is a severe complication in patients with decompensated liver cirrhosis and is commonly treated with broad spectrum antibiotics. However, the rise of antibiotic resistance requires alternative therapeutic strategies. As recently shown, human amnion-derived mesenchymal stem cells (hA-MSCs) are able, in vitro, to promote bacterial clearance and modulate the immune and inflammatory response in SBP. Our results highlight the upregulation of FOXO1, CXCL5, CXCL6, CCL20, and MAPK13 in hA-MSCs as well as the promotion of bacterial clearance, prompting a shift in the immune response toward a Th17 lymphocyte phenotype after 72 h treatment. In this study, we used an in vitro SBP model and employed omics techniques (next-generation sequencing) to investigate the mechanisms by which hA-MSCs modify the crosstalk between immune cells in LPS-stimulated ascitic fluid. We also validated the data obtained via qRT-PCR, cytofluorimetric analysis, and Luminex assay. These findings provide further support to the hope of using hA-MSCs for the prevention and treatment of infective diseases, such as SBP, offering a viable alternative to antibiotic therapy. Full article
(This article belongs to the Special Issue Liver Tissue Damage and Repair)
Show Figures

Figure 1

Back to TopTop